Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05VKW
|
||||
| Former ID |
DNC009486
|
||||
| Drug Name |
Sideroxylonal C
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [525438] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C26H28O10
|
||||
| Canonical SMILES |
CC(C)CC1C(C(OC2=C(C(=C(C(=C12)O)C=O)O)C=O)C3=C(C(=C(C(=<br />C3O)C=O)O)C=O)O)C(C)C
|
||||
| InChI |
1S/C26H28O10/c1-10(2)5-12-17(11(3)4)26(19-23(34)13(6-27)20(31)14(7-28)24(19)35)36-25-16(9-30)21(32)15(8-29)22(33)18(12)25/h6-12,17,26,31-35H,5H2,1-4H3/t12-,17-,26-/m1/s1
|
||||
| InChIKey |
PHQDMQGEKNBIPF-RAFFTOIBSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Plasminogen activator inhibitor-1 | Target Info | Inhibitor | [525438] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| p73 transcription factor network | |||||
| E2F transcription factor network | |||||
| HIF-2-alpha transcription factor network | |||||
| Direct p53 effectors | |||||
| Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | |||||
| HIF-1-alpha transcription factor network | |||||
| WikiPathways | Senescence and Autophagy in Cancer | ||||
| TGF Beta Signaling Pathway | |||||
| Complement and Coagulation Cascades | |||||
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | |||||
| Blood Clotting Cascade | |||||
| Extracellular matrix organization | |||||
| Oncostatin M Signaling Pathway | |||||
| Adipogenesis | |||||
| Dissolution of Fibrin Clot | |||||
| Circadian Clock | |||||
| Folate Metabolism | |||||
| Vitamin B12 Metabolism | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.